Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PRVA · against 320 other Healthcare companies of similar size
Ranked #76 of 321 · scores higher than 75% of peers
Bars: peers in each 10-point band of the growth score42 peers with a growth score of 80–89, including PRVA · Click a bar to see the companies
Mainly thanks to its earnings per share growth, revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | PRVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 320 reported | 24.1% | 7.2% | 80% | 33% | |
| Earnings per share growthHigher is better · 194 reported | 82.1% | 10.5% | 82% | 33% | |
| 3-year revenue growthHigher is better · 313 reported | 16.1% | 7.9% | 73% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 76 | 15.6B CNY (≈$2.2B) | 81 | 79 | |
| 76 | 249.2B INR (≈$3.0B) | 81 | 73 | |
| 76 | 379.9B INR (≈$4.6B) | 81 | 55 | |
| 76 | 1.5B USD | 81 | 65 | |
| 76 | 2.7B USD | 81 | 56 | |
| 82 | 231.7B JPY (≈$1.6B) | 80 | 61 | |
| 82 | 3.5B USD | 80 | 75 | |
| 84 | 15.8B HKD (≈$2.0B) | 79 | 61 | |
| 84 | 222.9B JPY (≈$1.5B) | 79 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score